Glaucoma News and Research

Latest Glaucoma News and Research

A unique new non-invasive technique for high resolution optical imaging of the eye

The technique, pioneered by the University of Kent, is funded by the Toronto-based company, Ophthalmic Technology Inc (OTI). The University’s Applied Optics Group is currently working with university hospitals in New York (USA), Osaka (Japan), Asahikawa (Japan), Amsterdam (Netherlands) and Milan (Italy) to carry out preliminary clinical trials.

12 Oct 2004

Significance of central corneal thickness on the management of glaucoma

In a new study, researchers at Columbia University Medical Center demonstrated the significance of central corneal thickness (CCT) on the clinical management of patients with glaucoma and those suspected to have glaucoma.

23 Sep 2004

THC in marijuana may block the spread of forms of cancer causing herpes viruses

The compound in marijuana that produces a high, delta-9 tetrahydrocannbinol or THC, may block the spread of several forms of cancer causing herpes viruses, University of South Florida College of Medicine scientists report.

22 Sep 2004

Cancer drug effective at treating lupus

A drug now used to treat a type of cancer appears to be very effective at treating lupus, with just one injection easing symptoms in several patients for a year or more.

16 Sep 2004

New glaucoma risk assessment principles help physicians decide who needs treatment

A new approach for assessing glaucoma risk factors could be the first step in helping ophthalmologists determine the risk of progression from ocular hypertension to glaucoma and blindness, according to an article published today in the September issue of the American Journal of Ophthalmology.

14 Sep 2004

Thickness of the cornea an important factor in considering treatment options for patients with glaucoma

Thickness of the cornea, the thin, transparent layer covering the eye, may be an important factor in considering treatment options for patients with glaucoma, according to an article appearing in the September issue of The Archives of Ophthalmology, one of the JAMA/Archives journals.

12 Sep 2004

New device aimed at detecting glaucoma

The physician who revolutionized screening methods for glaucoma nearly 20 years ago has patented a new device aimed at detecting glaucoma, a leading cause of blindness.

10 Sep 2004

New spectral imaging technique will help diagnosis of glaucoma, diabetic retinopathy and age related macula degeneration

A new way of taking pictures of the retina could give medics a powerful new tool in diagnosing and monitoring the most prevalent diseases of the eye - glaucoma, diabetic retinopathy, and age related macula degeneration.

8 Sep 2004

Cymbalta approved for diabetic peripheral neuropathy pain

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.

8 Sep 2004

First step in using gene therapy to treat glaucoma

Mayo Clinic researchers have demonstrated they can permanently transfer a functioning gene to targeted tissues within the eye.

2 Sep 2004

Pfizer drug effectively treats overactive bladder symptoms

Women with mixed incontinence, a combination of overactive bladder and stress incontinence, reported a greater treatment benefit for overactive bladder symptoms from DETROL® LA (tolterodine tartrate extended release capsules) than placebo, according to new study results published in the August issue of Urology.

21 Aug 2004

Latinos living in the United States have high rates of eye disease and visual impairment

Researchers found that Latinos had high rates of diabetic retinopathy, an eye complication of diabetes; and open-angle glaucoma, a disease that damages the optic nerve.

9 Aug 2004

New drugs that can prevent scarring in the eye after glaucoma surgery

Highly innovative new drugs that can prevent scarring in the eye after glaucoma surgery have been discovered by a London-based team of scientists, who report today in the journal Nature Biotechnology.

19 Jul 2004

Cataract more prevalent in African American nursing home residents than white residents

A cataract is a cloud or film that can form on the lens of a person's eye. The presence of a cataract can degrade the quality of one's vision by blocking and scattering light as it enters the eye. It is often associated with chronic exposure to ultraviolet radiation.

13 Jul 2004

Latanoprost is safe as adjunctive therapy for long-term treatment of common form of glaucoma

Glaucoma is a condition in which the pressure inside the eyes rises. If untreated, glaucoma may damage the optic nerve and other parts of the eye, and my lead to blindness. According to information in the article, latanoprost is a derivative of the chemical prostaglandin F2-alpha. Prostaglandin derivatives have been shown to help lower intraocular pressure (IOP).

13 Jul 2004

The medical use of marijuana

The medical use of marijuana enjoys wide public support. More than 70% of respondents to recent surveys agree that marijuana should be available medically. Sources: Pew Research Center for the People & the Press conducted by Princeton Survey Research Associates. Feb. 14-19, 2001 and The Gallup Poll. March 19-21, 1999.

30 Jun 2004

U.S. Supreme Court to decide whether anti-drug laws should apply to the medicinal use of marijuana

The U.S. Supreme Court is to decide whether anti-drug laws should apply to the medicinal use of marijuana.

29 Jun 2004

Alarming rise in the number of patients treated for eye injuries caused by paintballs

As part of Eye Injury Prevention month in July, the American Academy of Ophthalmology -- the Eye M.D. Association -- warns the public about the dangers of paintballs to the eyes.

22 Jun 2004

$2 million to advance medical research in Australia

Fourteen leading medical research teams across Australia have been granted $2 million by the Commonwealth Government to advance their medical research projects.

17 Jun 2004

Support for the medical use of marijuana

Manhattan District Attorney Robert M. Morgenthau has announced his support for the medical use of marijuana. The District Attorney was joined by Montel Williams in announcing support for legislation introduced by New York State Assemblyman Richard Gottfried.

16 Jun 2004

Glaucoma News and Research

Latest Glaucoma News and Research

A unique new non-invasive technique for high resolution optical imaging of the eye

Significance of central corneal thickness on the management of glaucoma

THC in marijuana may block the spread of forms of cancer causing herpes viruses

Cancer drug effective at treating lupus

New glaucoma risk assessment principles help physicians decide who needs treatment

Thickness of the cornea an important factor in considering treatment options for patients with glaucoma

New device aimed at detecting glaucoma

New spectral imaging technique will help diagnosis of glaucoma, diabetic retinopathy and age related macula degeneration

Cymbalta approved for diabetic peripheral neuropathy pain

First step in using gene therapy to treat glaucoma

Pfizer drug effectively treats overactive bladder symptoms

Latinos living in the United States have high rates of eye disease and visual impairment

New drugs that can prevent scarring in the eye after glaucoma surgery

Cataract more prevalent in African American nursing home residents than white residents

Latanoprost is safe as adjunctive therapy for long-term treatment of common form of glaucoma

The medical use of marijuana

U.S. Supreme Court to decide whether anti-drug laws should apply to the medicinal use of marijuana

Alarming rise in the number of patients treated for eye injuries caused by paintballs

$2 million to advance medical research in Australia

Support for the medical use of marijuana

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Glaucoma News and Research

Latest Glaucoma News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in